IRAK3 anticorps (C-Term)
Aperçu rapide pour IRAK3 anticorps (C-Term) (ABIN633596)
Antigène
Voir toutes IRAK3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- IRAK3 antibody was raised against the C terminal of IRAK3
-
Purification
- Affinity purified
-
Immunogène
- IRAK3 antibody was raised using the C terminal of IRAK3 corresponding to a region with amino acids NTLESTQASLYFAEDPPTSLKSFRCPSPLFLENVPSIPVEDDESQNNNLL
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
IRAK3 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this IRAK3 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of IRAK3 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- IRAK3 (Interleukin-1 Receptor-Associated Kinase 3 (IRAK3))
-
Autre désignation
- IRAK3
-
Sujet
- IRAK3 contains 1 protein kinase domain and 1 death domain and belongs to the Ser/Thr protein kinase family, Pelle subfamily. It inhibits dissociation of IRAK1 and IRAK4 from the Toll-like receptor signaling complex by either inhibiting the phosphorylation of IRAK1 and IRAK4 or stabilizing the receptor complex.
-
Poids moléculaire
- 66 kDa (MW of target protein)
-
Pathways
- Signalisation TLR, Activation of Innate immune Response, Production of Molecular Mediator of Immune Response, Toll-Like Receptors Cascades
Antigène
-